Found 29 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Ophthalmology
-
Currently Recruiting
Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
We are seeking participants for a new clinical research study to evaluate the long term treatment effects of an investigational medication on diabetic retinopathy progression in adults with type 2 diabetes.
- 72 views
- 14 Jan, 2021
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
We are currently recruiting participants for a clinical research trial to see if a study medication may reduce the risk of having cardiovascular events in non-diabetic overweight or obese patients with a prior history of a cardiovascular event.
- 82 views
- 14 Jan, 2021
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
EX9924-4473: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL)
Oral Semaglutide
- 90 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
16-week Flexible vs. 8-week Semaglutide Titration
Semaglutide is a Glucagon Like Peptide 1 (GLP-1) receptor agonist recently approved in Israel to improve glycemic control in patients with type 2 diabetes mellitus. Semaglutide is currently
- 0 views
- 25 Jan, 2021
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Current anti-diabetic treatment fails to stop the progressive course of the disease. Recent studies have revealed a surprisingly high variability in the diabetic phenotype. The investigators propose that anti-diabetic treatment should ideally target the underlying pathophysiology of each individual patient. The investigators will therefore test whether the effect of two …
- 0 views
- 25 Jan, 2021
- 1 location
-
Phase 1 trial
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
The goal of this trial is to find out whether taking semaglutide tablets at different times before and after eating has a similar effect compared to the recommended dosing time. Participants
- 0 views
- 25 Jan, 2021
- 1 location
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or
- 1276 views
- 17 Jan, 2021
- 553 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Psychiatry/Psychology
-
Currently Recruiting
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity
This study will look at the change in body weight from the start to the end of the study. The purpose of the study is to compare the effect on body weight in people taking semaglutide (a new
- 0 views
- 11 Jan, 2021
- 22 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
An interventional trial
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The
- 7712 views
- 19 Jan, 2021
- 1159 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested to see how well it works compared to the dummy medicine
- 0 views
- 17 Jan, 2021
- 39 locations